Read More Pharma Industry News Rubicon Research Rs 140cr pre-IPO boost: Can the pharma firm deliver sustained growth? Rubicon Research secures ₹140 crore from TIMF Holdings and 360 ONE Funds ahead of IPO. Find out how the pharma player is positioning for growth. byPallavi MadhirajuSeptember 22, 2025